NasdaqGM - Delayed Quote USD
Structure Therapeutics Inc. (GPCR)
23.89
-0.73
(-2.97%)
At close: May 13 at 4:00:02 PM EDT
24.04
+0.15
+(0.63%)
After hours: May 13 at 6:13:02 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.71M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| STEVENS RAYMOND C Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| HALL ASHLEY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| LIN XICHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| YOON JUN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| COLL CRESPO BLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| HALL ASHLEY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 18, 2024 |
| COLL CRESPO BLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 18, 2024 |
| LIN XICHEN Officer | Conversion of Exercise of derivative security at price 52.74 per share. | Direct | 5,600,988 | Jun 3, 2024 |
| LIN XICHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 15, 2024 |
| BACH MARK ALLEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 15, 2024 |
Related Tickers
TERN Terns Pharmaceuticals, Inc.
2.9000
-3.97%
VKTX Viking Therapeutics, Inc.
27.74
-2.00%
ALT Altimmune, Inc.
5.76
-4.16%
AKRO Akero Therapeutics, Inc.
40.01
-3.66%
MGX Metagenomi, Inc.
1.6000
+3.23%
MDGL Madrigal Pharmaceuticals, Inc.
295.36
-1.80%
MTSR Metsera, Inc.
26.10
-1.06%
CYTK Cytokinetics, Incorporated
30.61
-4.73%
DYN Dyne Therapeutics, Inc.
12.10
-3.66%
RVMD Revolution Medicines, Inc.
39.95
-4.61%